Gordeeva A E, Temnov A A, Charnagalov A A, Sharapov M G, Fesenko E E, Novoselov V I
Institute of Cell Biophysics, Russian Academy of Sciences, 3, Institutskaya, Pushchino, Moscow Region, Russia, 142290.
N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department, Moscow, Russia.
Dig Dis Sci. 2015 Dec;60(12):3610-9. doi: 10.1007/s10620-015-3809-3. Epub 2015 Aug 2.
Strong oxidative stress starting in the epithelium upon restoration of blood cell circulation is a major cause of necrosis of the intestinal epithelium in ischemia/reperfusion-induced damage.
The purpose of this study was to investigate the tissue-protective effect of exogenous peroxiredoxin 6 (Prx6) in ischemia/reperfusion-induced damage of small intestine.
The research was carried out using a model of acute superior mesenteric artery occlusion in Wistar male rats. Exogenous Prx6 was administrated intravenously 15 min prior to small intestine ischemia. The distribution of endogenous Prx6 in the small intestine was determined by immunohistochemical analysis. The expression level of antioxidant enzymes was evaluated by RT-PCR in real time.
Exogenous Prx6 injected to animals intravenously was detected in blood vessel lumens, and its diffuse distribution was subsequently confirmed in the intestinal epithelium. Expression analysis of genes coding for major antioxidant enzymes demonstrated a significant activation of SOD 1, SOD 3, Prx6, GPx2, GPx7 expression during I/R-induced damage of the small intestine. Injection of exogenous Prx6 prior to induced ischemia resulted in minimization of oxidative injury by reducing necrosis and apoptosis, by normalization of gene activity of antioxidant enzyme. It eventually led to a reduction of epithelium destruction in the small intestine. By contrast, administration of a purified mutant form of Prx6 (Prx6C47S) without peroxidase activity had no protective effect.
The application of exogenous Prx6 enables normalization of the antioxidant status of the small intestine and reduction of cell destruction upon I/R-induced organ damage.
血细胞循环恢复后上皮细胞开始出现的强烈氧化应激是缺血/再灌注损伤中肠上皮坏死的主要原因。
本研究旨在探讨外源性过氧化物还原酶6(Prx6)对缺血/再灌注诱导的小肠损伤的组织保护作用。
采用Wistar雄性大鼠急性肠系膜上动脉闭塞模型进行研究。在小肠缺血前15分钟静脉注射外源性Prx6。通过免疫组织化学分析确定内源性Prx6在小肠中的分布。通过实时RT-PCR评估抗氧化酶的表达水平。
静脉注射给动物的外源性Prx6在血管腔内被检测到,随后在肠上皮中证实其呈弥漫性分布。对主要抗氧化酶编码基因的表达分析表明,在小肠缺血/再灌注损伤期间,超氧化物歧化酶1(SOD 1)、超氧化物歧化酶3(SOD 3)、Prx6、谷胱甘肽过氧化物酶2(GPx2)、谷胱甘肽过氧化物酶7(GPx7)的表达有显著激活。在诱导缺血前注射外源性Prx6可通过减少坏死和凋亡、使抗氧化酶基因活性正常化来将氧化损伤降至最低。最终导致小肠上皮破坏减少。相比之下,给予无过氧化物酶活性的纯化突变形式Prx6(Prx6C47S)则没有保护作用。
外源性Prx6的应用可使小肠的抗氧化状态正常化,并减少缺血/再灌注诱导的器官损伤时的细胞破坏。